D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ATOS holding history
Atossa Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ATOS overviewAll 13F holders of ATOSFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −216,528−100.0% | Sold out | Holders |
| Q2 2023 | 216,528 | $272.8K | <0.1% | −606,834−73.7% | Reduced | Holders |
| Q1 2023 | 823,362 | $596.9K | <0.1% | −650,763−44.1% | Reduced | Holders |
| Q4 2022 | 1,474,125 | $779.1K | <0.1% | −293,212−16.6% | Reduced | Holders |
| Q3 2022 | 1,767,337 | $1.47M | <0.1% | −512,299−22.5% | Reduced | Holders |
| Q2 2022 | 2,279,636 | $2.48M | <0.1% | −1,583,499−41.0% | Reduced | Holders |
| Q1 2022 | 3,863,135 | $4.83M | <0.1% | −284,674−6.9% | Reduced | Holders |
| Q4 2021 | 4,147,809 | $6.64M | <0.1% | +3,251,752+362.9% | Added | Holders |
| Q3 2021 | 896,057 | $2.92M | <0.1% | +896,057 | New | Holders |